Market closed

Ginkgo Bioworks/$DNA

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Ginkgo Bioworks

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.

Ticker

$DNA
Sector

Trading on

NYSE

Industry

Chemicals

Employees

1,218

Ginkgo Bioworks Metrics

BasicAdvanced
$568M
Market cap
-
P/E ratio
-$12.86
EPS
1.10
Beta
-
Dividend rate
$568M
1.1
$75.20
$5.26
1.3M
5.79
5.594
55.843
55.843
-5,681.02%
-19.19%
-63.51%
2.494
0.71
0.79
-1.404
-30.81%
-28.40%
3.36%
14.64%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DNA

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ginkgo Bioworks stock?

Ginkgo Bioworks (DNA) has a market cap of $568M as of December 11, 2024.

What is the P/E ratio for Ginkgo Bioworks stock?

The price to earnings (P/E) ratio for Ginkgo Bioworks (DNA) stock is 0 as of December 11, 2024.

Does Ginkgo Bioworks stock pay dividends?

No, Ginkgo Bioworks (DNA) stock does not pay dividends to its shareholders as of December 11, 2024.

When is the next Ginkgo Bioworks dividend payment date?

Ginkgo Bioworks (DNA) stock does not pay dividends to its shareholders.

What is the beta indicator for Ginkgo Bioworks?

Ginkgo Bioworks (DNA) has a beta rating of 1.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.